Immediate Impact
2 standout
Citing Papers
Therapeutic strategies for COVID-19: progress and lessons learned
2023 Standout
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
2022 Standout
Works of Kenneth Sutton being referenced
116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study
2020
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kenneth Sutton | 72 | 61 | 10 | 12 | 15 | 83 | |
| Sara Modica | 54 | 49 | 11 | 11 | 8 | 69 | |
| Claudine Bernard-Henry | 77 | 57 | 24 | 26 | 10 | 97 | |
| Iván Chivite | 84 | 52 | 23 | 34 | 18 | 90 | |
| Dorcas Maruapula | 68 | 59 | 9 | 4 | 17 | 76 | |
| A Scasso | 88 | 41 | 28 | 16 | 10 | 167 | |
| Rafael Micán | 45 | 33 | 26 | 19 | 18 | 69 | |
| Ndèye Méry Dia Badiane | 143 | 120 | 34 | 7 | 16 | 161 | |
| Suzanne M. McCluskey | 142 | 118 | 31 | 10 | 25 | 173 | |
| Christine Cheneau | 75 | 51 | 28 | 28 | 10 | 97 | |
| Amj Wensing | 58 | 72 | 11 | 10 | 8 | 80 |
All Works
Loading papers...